The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 ...

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

The rate of warnings initiated by the FDA continues to rise in the pharma and medical device industries. Knowing how to best ...

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

In a warning letter posted online late last month, the FDA scolded Viatris over a range of production slights at the ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.

The FDA also sent a letter to gas stations and convenience ... The Federal Drug Administration has issued a warning against ...

In a regulatory filing on Monday, Integra LifeSciences (IART) said that on December 19, 2024, a subsidiary received a warning letter from the ...

Fagron (ARSUF) has refocused its M&A strategy, regaining market trust despite recent FDA issues. Read why I think the stock ...

On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel ...